| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011508946 |
| P356 | DOI | 10.1186/1756-3305-5-273 |
| P932 | PMC publication ID | 3547689 |
| P698 | PubMed publication ID | 23181694 |
| P5875 | ResearchGate publication ID | 233771615 |
| P50 | author | Shenyi He | Q79290973 |
| Huaiyu Zhou | Q114536212 | ||
| Qunli Zhao | Q114536213 | ||
| Xing-Quan Zhu | Q60451763 | ||
| P2093 | author name string | Yang Bai | |
| Gang Lu | |||
| Min Meng | |||
| Guanghui Zhao | |||
| Hua Cong | |||
| P2860 | cites work | Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. | Q24520491 |
| Immune response and immunopathology during toxoplasmosis | Q24612341 | ||
| Toxoplasma gondii: from animals to humans | Q24622583 | ||
| Toxoplasmosis: A history of clinical observations | Q24655325 | ||
| 14-3-3 proteins: structure, function, and regulation | Q29619100 | ||
| Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge | Q80398291 | ||
| The protective effect of a Toxoplasma gondii SAG1 plasmid DNA vaccine in mice is enhanced with IL-18 | Q82786243 | ||
| Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model | Q82871662 | ||
| Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant | Q83221345 | ||
| [DNA vaccines and recombinant antigens in prevention of Toxoplasma gondii infections--current status of the studies] | Q84385000 | ||
| Toxoplasmosis | Q30080013 | ||
| A 14-3-3 protein homologue is expressed in feline enteroepithelial-stages of Toxoplasma gondii | Q30653034 | ||
| Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents | Q33802504 | ||
| Biological role of surface Toxoplasma gondii antigen in development of vaccine | Q33868835 | ||
| Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. | Q34002711 | ||
| Toxoplasma gondii: epidemiology, feline clinical aspects, and prevention | Q34102118 | ||
| The history of Toxoplasma gondii--the first 100 years | Q34914431 | ||
| Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii | Q35176429 | ||
| DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice | Q35589002 | ||
| 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 | ||
| Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors | Q35794641 | ||
| Mechanisms of Toxoplasma gondii persistence and latency | Q35870650 | ||
| Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii | Q36367127 | ||
| Seroprevalence of Toxoplasma gondii infection in slaughtered chickens, ducks, and geese in Shenyang, northeastern China | Q36391621 | ||
| Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii | Q37056732 | ||
| Vaccination concepts against Toxoplasma gondii. | Q37386300 | ||
| Vaccines against Toxoplasma gondii: challenges and opportunities | Q37476759 | ||
| Current status of toxoplasmosis vaccine development. | Q37503262 | ||
| Immunogenetics of Toxoplasma gondii informs vaccine design | Q37767914 | ||
| Immunology of Toxoplasma gondii | Q37846877 | ||
| Toxoplasma in animals, food, and humans: an old parasite of new concern | Q37864331 | ||
| Vaccination programs for reproductive disorders of small ruminants | Q37988067 | ||
| New antibacterials for the treatment of toxoplasmosis; a patent review | Q37992089 | ||
| DNA vaccines for parasitic infections | Q39116292 | ||
| Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential | Q40155483 | ||
| A commercial vaccine for ovine toxoplasmosis. | Q40546683 | ||
| Characterization of an excreted/secreted antigen form of 14-3-3 protein in Toxoplasma gondii tachyzoites | Q40562699 | ||
| Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant | Q40745840 | ||
| Characterization of a carboxypeptidase inhibitor from the tick Haemaphysalis longicornis | Q42627052 | ||
| The 14-3-3 protein as a vaccine candidate against schistosomiasis | Q43572145 | ||
| Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara | Q44138669 | ||
| Subcellular localization of 14-3-3 proteins in Toxoplasma gondii tachyzoites and evidence for a lipid raft-associated form. | Q44533686 | ||
| TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii | Q44636873 | ||
| Interferon-gamma: the major mediator of resistance against Toxoplasma gondii | Q45128276 | ||
| Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy. | Q47391375 | ||
| A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts | Q49138754 | ||
| Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis | Q56769278 | ||
| Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice | Q73074969 | ||
| P921 | main subject | Toxoplasma gondii | Q131003 |
| P304 | page(s) | 273 | |
| P577 | publication date | 2012-11-26 | |
| P1433 | published in | Parasites and Vectors | Q7135941 |
| P1476 | title | Evaluation of protective immune responses induced by DNA vaccines encoding Toxoplasma gondii surface antigen 1 (SAG1) and 14-3-3 protein in BALB/c mice | |
| P478 | volume | 5 |
| Q61809093 | 14-3-3 Protein of Modulates Host Cell Innate Immunity Through the Activation of MAPK and NF-κB Pathways |
| Q36219021 | 14-3-3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis |
| Q57288901 | A 21.6 kDa tegumental protein of Clonorchis sinensis induces a Th1/Th2 mixed immune response in mice |
| Q54961728 | A recombinant Fasciola gigantica 14-3-3 epsilon protein (rFg14-3-3e) modulates various functions of goat peripheral blood mononuclear cells. |
| Q35033334 | Alpha-galactosylceramide enhances protective immunity induced by DNA vaccine of the SAG5D gene of Toxoplasma gondii |
| Q34333378 | Analyzing and identifying novel B cell epitopes within Toxoplasma gondii GRA4. |
| Q99630967 | Antigenic properties of dense granule antigen 12 protein using bioinformatics tools in order to improve vaccine design against Toxoplasma gondii |
| Q88911184 | Bioinformatics analysis of single and multi-hybrid epitopes of GRA-1, GRA-4, GRA-6 and GRA-7 proteins to improve DNA vaccine design against Toxoplasma gondii |
| Q35276317 | Cloning and Expression of Major Surface Antigen 1 Gene of Toxoplasma gondii RH Strain Using the Expression Vector pVAX1 in Chinese Hamster Ovary Cells |
| Q39271673 | Cloning and characterization of an Eimeria necatrix gene encoding a gametocyte protein and associated with oocyst wall formation |
| Q34501283 | Comparative efficacy of a multi-epitope DNA vaccine via intranasal, peroral, and intramuscular delivery against lethal Toxoplasma gondii infection in mice |
| Q36755477 | Compound DNA vaccine encoding SAG1/ SAG3 with A2/B subunit of cholera toxin as a genetic adjuvant protects BALB/c mice against Toxoplasma gondii |
| Q35023899 | DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice |
| Q34184744 | DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice |
| Q100525942 | Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice |
| Q24471805 | Epitope analysis and protection by a ROP19 DNA vaccine against Toxoplasma gondii |
| Q33882859 | Evaluation of immune protection induced by DNA vaccines from Haemaphysalis longicornis paramyosin in rabbits |
| Q33899385 | Evaluation of immune responses in mice after DNA immunization with putative Toxoplasma gondii calcium-dependent protein kinase 5. |
| Q35832857 | Functional analysis of Paracoccidioides brasiliensis 14-3-3 adhesin expressed in Saccharomyces cerevisiae |
| Q33798659 | Identification of common immunodominant antigens of Eimeria tenella, Eimeria acervulina and Eimeria maxima by immunoproteomic analysis |
| Q52675448 | Identification of two novel host proteins interacting with Toxoplasma gondii 14-3-3 protein by yeast two-hybrid system. |
| Q56567289 | Immunization With a DNA Vaccine Cocktail Encoding TgPF, TgROP16, TgROP18, TgMIC6, and TgCDPK3 Genes Protects Mice Against Chronic Toxoplasmosis |
| Q92630377 | Immunization of Goats with Recombinant Protein 14-3-3 Isoform 2(rHcftt-2) Induced Moderate Protection against Haemonchus contortus Challenge |
| Q90700591 | Immunogenicity of Multiepitope Vaccine Candidate against Toxoplasma gondii Infection in BALB/c Mice |
| Q36825131 | Immunogenicity of varicella zoster virus glycoprotein E DNA vaccine |
| Q36646902 | Induction of long-lasting protective immunity against Toxoplasma gondii in BALB/c mice by recombinant surface antigen 1 protein encapsulated in poly (lactide-co-glycolide) microparticles. |
| Q91713619 | Molecular Characterization and Immuno-Reactivity Patterns of a Novel Plasmodium falciparum Armadillo-Type Repeat Protein, PfATRP |
| Q56669444 | Pathological, immunological and parasitological study of sheep vaccinated with the recombinant protein 14-3-3z and experimentally infected with Fasciola hepatica |
| Q88235205 | Protective immunity against Eimeria maxima induced by vaccines of Em14-3-3 antigen |
| Q59136268 | Protective immunity induced by Eimeria common antigen 14-3-3 against Eimeria tenella, Eimeria acervulina and Eimeria maxima |
| Q44108100 | Protective immunity induced by a DNA vaccine-encoding Toxoplasma gondii microneme protein 11 against acute toxoplasmosis in BALB/c mice. |
| Q54241883 | Proteomic analysis of protein interactions between Eimeria maxima sporozoites and chicken jejunal epithelial cells by shotgun LC-MS/MS. |
| Q38303517 | Recent advances in Toxoplasma gondii immunotherapeutics |
| Q38204033 | Research progress on surface antigen 1 (SAG1) of Toxoplasma gondii |
| Q87410025 | Sustained release of recombinant surface antigen 2 (rSAG2) from poly(lactide-co-glycolide) microparticles extends protective cell-mediated immunity against Toxoplasma gondii in mice |
| Q40617803 | Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach |
| Q40548173 | The effect of chitosan nanospheres on the immunogenicity of Toxoplasma lysate vaccine in mice |
| Q34037687 | The extracellular matrix protein mindin as a novel adjuvant elicits stronger immune responses for rBAG1, rSRS4 and rSRS9 antigens of Toxoplasma gondii in BALB/c mice |
| Q38440784 | Unravelling the Neospora caninum secretome through the secreted fraction (ESA) and quantification of the discharged tachyzoite using high-resolution mass spectrometry-based proteomics |
| Q30096805 | Vaccination with recombinant adenovirus expressing multi-stage antigens of Toxoplasma gondii by the mucosal route induces higher systemic cellular and local mucosal immune responses than with other vaccination routes |
| Q38149266 | Vaccines against Toxoplasma gondii: new developments and perspectives |
Search more.